FR2207129A1 - - Google Patents

Info

Publication number
FR2207129A1
FR2207129A1 FR7340869A FR7340869A FR2207129A1 FR 2207129 A1 FR2207129 A1 FR 2207129A1 FR 7340869 A FR7340869 A FR 7340869A FR 7340869 A FR7340869 A FR 7340869A FR 2207129 A1 FR2207129 A1 FR 2207129A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7340869A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of FR2207129A1 publication Critical patent/FR2207129A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0025—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7340869A 1972-11-18 1973-11-16 Withdrawn FR2207129A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2257132A DE2257132C3 (de) 1972-11-18 1972-11-18 Verfahren zur Reduktion von 3-Ketosteroiden

Publications (1)

Publication Number Publication Date
FR2207129A1 true FR2207129A1 (fr) 1974-06-14

Family

ID=5862375

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7340869A Withdrawn FR2207129A1 (fr) 1972-11-18 1973-11-16

Country Status (11)

Country Link
US (1) US3875195A (fr)
JP (1) JPS5710879B2 (fr)
CH (1) CH586237A5 (fr)
CS (1) CS166850B2 (fr)
DD (1) DD108080A5 (fr)
DE (1) DE2257132C3 (fr)
DK (1) DK134782C (fr)
FR (1) FR2207129A1 (fr)
GB (1) GB1455578A (fr)
HU (1) HU166940B (fr)
NL (1) NL7315781A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987002672A1 (fr) * 1985-10-23 1987-05-07 The Upjohn Company Steroides tetrahydro-angiostatiques

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031117A (en) * 1975-09-22 1977-06-21 Becton, Dickinson And Company Testosterone derivatives
JPS60135171U (ja) * 1984-02-20 1985-09-07 株式会社エバニュ− ロ−ラ−スケ−トの車輪
JPS60135172U (ja) * 1984-02-20 1985-09-07 株式会社エバニュ− ロ−ラ−スケ−トの車輪
JPH01130377U (fr) * 1988-02-24 1989-09-05
ATE459636T1 (de) * 2002-10-28 2010-03-15 Phytopharm Plc Stereospezifische reduktion von sapogen-3-onen

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987002672A1 (fr) * 1985-10-23 1987-05-07 The Upjohn Company Steroides tetrahydro-angiostatiques
EP0221705A1 (fr) * 1985-10-23 1987-05-13 The Upjohn Company Tétrahydro-stéroides à activité angiostatique

Also Published As

Publication number Publication date
CH586237A5 (fr) 1977-03-31
GB1455578A (en) 1976-11-17
CS166850B2 (fr) 1976-03-29
US3875195A (en) 1975-04-01
DD108080A5 (fr) 1974-09-05
DE2257132A1 (de) 1974-05-30
DK134782B (da) 1977-01-17
HU166940B (fr) 1975-06-28
JPS4981360A (fr) 1974-08-06
DE2257132C3 (de) 1982-05-13
JPS5710879B2 (fr) 1982-03-01
DE2257132B2 (de) 1981-07-23
DK134782C (da) 1977-06-06
NL7315781A (fr) 1974-05-21

Similar Documents

Publication Publication Date Title
JPS5253194Y2 (fr)
CS158004B1 (fr)
CS156142B1 (fr)
CS154523B1 (fr)
CS153303B1 (fr)
CS153851B1 (fr)
CS160804B1 (fr)
CS160334B1 (fr)
CS159835B1 (fr)
CS153883B1 (fr)
CH581691A5 (fr)
CH584771A5 (fr)
CH570257A5 (fr)
CH570279A5 (fr)
CH570619A5 (fr)
CH571122A5 (fr)
CH572229A5 (fr)
CH575207A5 (fr)
CH576043A5 (fr)
CH576325A5 (fr)
CH578307A5 (fr)
CH579558A5 (fr)
CH580483A5 (fr)
CH580565A5 (fr)
CH553437A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse